Brian Freed PhD

Dr. Brian Freed leads RheumaGen’s R&D. He is Professor of Medicine and Immunology at the University of Colorado School of Medicine, Anschutz Medical Campus, and he is Founder and Executive Director of CU Anschutz’s ClinImmune, one of the largest nonprofit clinical laboratories in the U.S. ClinImmune has generated over $200M in clinical revenue. Dr. Freed is the lead inventor of RheumaGen’s breakthrough HLA gene-editing therapies. He is a world-class expert in the HLA gene, with over 40 years of experience and more than 100 publications in the areas of immunogenetics, biotherapeutics, histocompatibility, transplantation, and stem-cell banking.